Investors were willing to pay up on Tuesday to buy the fourth-biggest corporate bond sale on record. Bond investors gave a stamp of approval to drugmaker AbbVie’s plan to acquire its peer Allergan, best known as the maker of Botox products.
Trending:
AbbVie's $30 billion bond sale was Wall Street's biggest this year